These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 10198793)
21. Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults? Yeh SH; Mink CM Drugs; 2006; 66(6):731-41. PubMed ID: 16706548 [TBL] [Abstract][Full Text] [Related]
22. [Efficacy of acellular pertussis vaccines]. Wirsing von König CH; Finger H Immun Infekt; 1995 Aug; 23(4):125-9. PubMed ID: 7558115 [TBL] [Abstract][Full Text] [Related]
23. Bordetella pertussis: why is it still circulating? Guiso N J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807 [TBL] [Abstract][Full Text] [Related]
24. Pertussis vaccines: WHO position paper - September 2015. Wkly Epidemiol Rec; 2015 Aug; 90(35):433-58. PubMed ID: 26320265 [No Abstract] [Full Text] [Related]
25. [Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults]. Zawadka M; Lutyńska A Przegl Epidemiol; 2012; 66(1):99-105. PubMed ID: 22708307 [TBL] [Abstract][Full Text] [Related]
26. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine. Bolotin S; Harvill ET; Crowcroft NS Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079 [TBL] [Abstract][Full Text] [Related]
27. Is there a need for a new generation of vaccines against pertussis? Storsaeter J; Wolter J Expert Opin Emerg Drugs; 2006 May; 11(2):195-205. PubMed ID: 16634696 [TBL] [Abstract][Full Text] [Related]
28. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Witt MA; Katz PH; Witt DJ Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127 [TBL] [Abstract][Full Text] [Related]
29. Pertussis: Where did we go wrong and what can we do about it? Locht C J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992 [TBL] [Abstract][Full Text] [Related]
30. Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Halperin SA; Scheifele D; Barreto L; Pim C; Guasparini R; Medd L; Meekison W; Eastwood BJ Pediatr Infect Dis J; 1999 Sep; 18(9):772-9. PubMed ID: 10493336 [TBL] [Abstract][Full Text] [Related]
32. [Pertussis vaccines: acellular versus whole cell. Perhaps a return to the past?]. Cofré J Rev Chilena Infectol; 2015 Oct; 32(5):559-63. PubMed ID: 26633113 [TBL] [Abstract][Full Text] [Related]
33. Pertussis control: time for something new? Clark TA; Messonnier NE; Hadler SC Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804 [TBL] [Abstract][Full Text] [Related]
34. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393 [TBL] [Abstract][Full Text] [Related]
35. Clinical trials of acellular pertussis vaccine in Sweden. An attempt to solve the problem of pertussis vaccination. Olin P Ann Sclavo Collana Monogr; 1986; 3(1-2):165-72. PubMed ID: 2892504 [No Abstract] [Full Text] [Related]
36. Prevention of pertussis: An unresolved problem. Esposito S; Principi N Hum Vaccin Immunother; 2018; 14(10):2452-2459. PubMed ID: 29856680 [TBL] [Abstract][Full Text] [Related]